RT Journal Article
T1 The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem.
A1 Ortiz, Alberto
A1 Sanchez-Niño, Maria Dolores
A1 Crespo-Barrio, Marta
A1 De-Sequera-Ortiz, Patricia
A1 Fernández-Giráldez, Elvira
A1 García-Maset, Rafael
A1 Macía-Heras, Manuel
A1 Pérez-Fontán, Miguel
A1 Rodríguez-Portillo, Mariano
A1 Salgueira-Lazo, Mercedes
A1 Sánchez-Álvarez, Emilio
A1 Santamaría-Olmo, Rafael
A1 Simal-Blanco, Fernando
A1 Pino-Pino, Maria Dolores
K1 Chronic kidney disease
K1 Clasificación
K1 Enfermedad renal crónica
K1 Financiación de la investigación
K1 Mortalidad
K1 Mortality
K1 Public health
K1 Ranking
K1 Research funding
K1 Salud pública
AB The Global Burden of Disease (GBD) study measures the health of populations worldwide and by country on an annual basis and aims at helping guide public policy on health issues. The GBD estimates for Spain in 2016 and recent trends in mortality and morbidity from 2006 to 2016 were recently published. According to these estimates, chronic kidney disease was the 8th cause of death in Spain in 2016. Among the top ten causes of death, chronic kidney disease was the fastest growing from 2006 to 2016, after Alzheimer disease. At the current pace of growth, chronic kidney disease is set to become the second cause of death in Spain, after Alzheimer disease, by 2100. Additionally, among major causes of death, chronic kidney disease also ranked second only to Alzheimer as the fastest growing cause of Years Lived with Disability (YLDs) and Disability Adjusted Life Years (DALYs). Public resources devoted to prevention, care and research on kidney disease should be in line with both its current and future burden.
YR 2018
FD 2018-11-28
LK http://hdl.handle.net/10668/13266
UL http://hdl.handle.net/10668/13266
LA en
LA es
DS RISalud
RD Apr 11, 2025